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Abstract
Background: Finding effective intervention strategies to combat rising obesity levels could significantly reduce the
burden that obesity and associated non-communicable diseases places on both individuals and the National Health
Service.
Methods: In this parallel randomised-controlled trial, 76 participants who are overweight or obese (50 female) were
given free access to a fitness centre for the duration of the 12-week intervention and randomised to one of three
interventions. The commercial intervention, the Healthy Weight Programme, (HWP, n = 25, 10/15 men/women)
consisted of twelve 1-h nutrition coaching sessions with a nutritionist delivered as a mixture of group and 1 to 1
sessions. In addition, twice-weekly exercise sessions (24 in total) were delivered by personal trainers for 12 weeks.
The NHS intervention (n = 25, 8/17 men/women) consisted of following an entirely self-managed 12-week online
NHS resource. The GYM intervention (n = 26, 8/18 men/women) received no guidance or formal intervention. All
participants were provided with a gym induction for safety and both the NHS and GYM participants were
familiarised with ACSM physical activity guidelines by way of a hand-out.
Results: The overall follow-up rate was 83%. Body mass was significantly reduced at post-intervention in all groups
(HWP: N = 18, − 5.17 ± 4.22 kg, NHS: N = 21–4.19 ± 5.49 kg; GYM: N = 24–1.17 ± 3.00 kg; p < 0.001) with greater
reductions observed in HWP and NHS groups compared to GYM (p < 0.05). Out with body mass and BMI, there
were no additional statistically significant time x intervention interaction effects.
Conclusions: This is the first study to evaluate the efficacy of both a free online NHS self-help weight-loss tool and
a commercial weight loss programme that provides face-to-face nutritional support and supervised exercise. The
findings suggest that both interventions are superior to an active control condition with regard to eliciting short-
term weight-loss.
Trial registration: ISRCTN Registry - ISRCTN31489026. Prospectively registered: 27/07/16.
Keywords: Weight loss, Exercise, Weight reduction programs
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: Benjamin.kelly@nuffieldhealth.com
1Nuffield Health Research Group, Nuffield Health, Ashley Avenue, Epsom,
Surrey KT18 5AL, UK
2Faculty of Health, Psychology and Social Care, Manchester Metropolitan
University, Manchester M15 6GX, UK
Full list of author information is available at the end of the article
Innes et al. BMC Public Health         (2019) 19:1732 
https://doi.org/10.1186/s12889-019-8061-x
Background
Responsible for nearly two thirds of deaths worldwide
[1], non-communicable diseases (NCD’s) represent a sig-
nificant global risk. In the UK, the probability of dying
between the ages of 30 and 70 years from one of the four
main NCDs is estimated to be ~ 12% [2]. In England, it
is estimated that at least 1 in 20 people has type-2-
diabetes (T2DM) [3], with future trends predicting to
rise by nearly a third to over four million diagnosed
cases by 2025 [4]. In Scotland alone, where two thirds of
adults are either overweight or obese, almost 20% of
adults over the age of 16 years have some form of
cardiovascular disease or T2DM [5].Obesity places a sig-
nificant financial burden upon the National Health
Services (NHS). Increased incidence of obesity parallels
that of NCD’s, with excess weight contributing to ap-
proximately 44% of the global T2DM burden [6]. With
co-morbidities such as hypertension [7] and dyslipidae-
mia [8], augmented by obesity, there is a pressing need
for effective interventional strategies. Previous projec-
tions have suggested that reducing body mass index
(BMI) by 1% across the UK population (equivalent to 1
kg weight loss) would substantially reduce burden, sav-
ing up to 202,000 incident cases of T2DM and 122,000
cases of cardiovascular diseases over 20 years [9].
Guidelines recommend that primary care physicians
in Britain identify people with obesity and offer clinical
management [10] but few options for treatment exist in
traditional primary care settings. Data from NHS-led
interventions is sparse. Research has suggested that the
12-week ‘Size down Programme’; an NHS group-based
programme led by food advisers recruited from the
local community, achieves significant weight loss, simi-
lar to competitor groups (Weight Watchers, Slimming
World, Rosemary Conley, All n = 100) [11]. The NHS
also provides a free, online, self-help tool [12]. This
weight loss plan was developed in association with The
British Dietetic Association, and according to the NHS
website, has been downloaded more than 4 million
times as of August 2019. The plan involves download-
ing and following 12 weekly information packs which
provide advice on both healthy eating and physical
activity covering topics including: portion control,
building-up physical activity, food swaps, comfort eat-
ing and long-term maintenance. Although this calorie-
restricted diet plan can be expected to be effective if
adhered to, it remains uncertain whether an online
programme will be sufficiently motivating to ensure ad-
herence. It has been suggested that supervised diet
plans have a greater chance of establishing and main-
taining weight loss [13]. To our knowledge, the NHS
weight loss plan has not previously been validated in
any cohort, so questions remain about the effectiveness
of this intervention.
To improve motivation and adherence, many commer-
cial programmes share a similar structure of once-
weekly group sessions ranging from 60 to 90min.
Educational content within commercial programmes is
predominantly focussed on dietary manipulation and
tracking, with energy deficit the central physiological
component to weight loss. Generally, activity is encour-
aged and is usually guided via measurable metrics such
as steps. Jebb and colleagues [14] demonstrated that fol-
lowing a 12-month commercial weight loss intervention
participants had increased odds of losing 5 and 10% of
initial body weight in comparison to participants receiv-
ing standard care (weight loss advice from a primary
care professional following national guidelines of the
country of the participant; UK, Germany or Australia). A
large (N = 29,326) participant data set from NHS refer-
rals to a commercial weight loss programme identified
that 57% of participants lost at least 5% of initial body
weight with 12% losing 10% of initial body weight after
just 12 sessions [15], with a number of studies replicat-
ing comparable findings across similar if not identical
commercial interventions [16–20]. The ‘Healthy Weight
Program’ (HWP) is a commercial, individually tailored
12-week intervention that provides both exercise and
nutritional support. Dedicated face-to-face exercise
coaching is delivered by personal trainers and face-to-
face nutrition coaching is delivered by registered nutri-
tionists across multiple days of the week with the
purpose of eliciting lifestyle and behaviour change to im-
prove health and wellbeing in individuals. To date no re-
search has compared a commercial intervention that
combines intensive face-to-face support targeting both
nutritional and exercise interventions to target weight
loss with a less resource-intensive programmes such as
the free online NHS weight loss tool.
The primary aim of the present study was to evaluate
the effectiveness of reducing body mass through the
scalable NHS resource compared to a commercial
resource-intensive weight-loss intervention; as well as a
‘no-advice’ comparator group. The secondary aim of the
present study was to evaluate the effectiveness of both
interventions at improving health indicators related to
obesity. We hypothesised that the HWP programme
would result in significantly greater losses in body mass
compared to the NHS weight loss programme. We fur-
ther hypothesised that both programmes would elicit
greater weight-loss than the ‘no-advice’ comparator
group.
Methods
Participants
Participants for this parallel-randomized control trial
were recruited from the local community near to the
trial site (Glasgow, UK) via various advertising
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approaches including email, online features and social
media in July and August 2016. People were directed to
a purpose-built web page which provided greater detail,
inclusion/exclusion criteria and an online contact form.
Participant inclusion criteria included: aged between 18
and 50 years; a body mass index (BMI) between 30 and
45 kg/m2; not currently regularly exercising assessed as
‘low’ via categorical scoring of the International Physical
Activity Questionnaire [21]; not currently dieting nor
have done so recently; not a current member of any
Nuffield Health Fitness and Wellbeing centres; able to
commit to visiting the trial sites 3–4 times per week for
the duration of the intervention; not pregnant or lactat-
ing; not undergoing treatment for, possession or diagno-
ses of any metabolic or cardiovascular disease and
previous surgical procedures for weight loss. Participants
with controlled hypertension remained eligible for the
trial. Individuals with a blood pressure (BP) of > 140/90
mmHg were eligible to proceed upon approval and con-
sent from their registered general practitioner. Pre-
screening of participants took place in July and August
2016 with the interventions taking place from September
2016 until January 2017 depending upon participant
start date.
Following initial screening, 76 participants (26 male,
50 female) were invited to proceed to the intervention
stage and provided written informed consent. Partici-
pants were block randomised by computer programme
(https://www.randomizer.org) to one of three interven-
tions: Healthy Weight Programme™ (HWP), National
Health Service programme (NHS), or gym only com-
parator group (GYM). Due to the nature of the interven-
tion, blinding was not possible. The University of Bath
Research Ethics Advisory Committee approved this
study (ref: EP 15/16259/283). Following completion of
the intervention phase, participants in all three groups
were given full access to a Nuffield Health Fitness &
Wellbeing Centre for 12 months to assist them in
achieving and maintaining any reduction in body
mass and as a reimbursement for their time during
the intervention. The CONSORT reporting guidelines
were used [22].
Healthy weight Programme
The 12-week HWP intervention consisted of ten nutri-
tion coaching sessions and 20 exercise sessions. The ten
1-h nutrition sessions were delivered by a registered nu-
tritionist and consisted of a mix of one-to-one appoint-
ments and group classes. Two sessions were reserved for
individual progress evaluations, specifically at weeks 6
and 10. Core themes included hunger and portions size,
emotional eating, effects of sleep and stress, fuelling ex-
ercise, common weight loss myths, snacking, goal setting
and meal planning. In addition, qualified exercise
professionals provided twice-weekly exercise sessions for
10 weeks, starting at 30 min per session and increasing
to 45 min by the end of the trial. Like the nutrition inter-
vention, 2 weeks were reserved for individual progress
evaluations. Sessions included indoor cycling, body
weight circuit training, body pump classes and high-
intensity interval training. Outside of structured fitness
sessions, participants had free access to the swimming
pool, gym and fitness classes but were not allowed to ac-
cess personal training other than what was provided as
part of the intervention.
NHS Programme
The 12-week NHS intervention is an entirely self-
managed online resource [12]. Participants were encour-
aged to utilise the broader NHS choices network and
associated online tools and apps such as recipe finder,
meal planner, calorie tracker and a moderated weight
loss social forum. In brief, this intervention involved par-
ticipants downloading weekly modules from the NHS
website within which standardised tasks and guidance
were detailed. Content included information on fibre
consumption, portion control, exercise preparation,
building-up physical activity, motivation strategy, break-
fast advice, workplace wellbeing, cravings, alcohol aware-
ness, plateaus, peer pressure, dining out, foreign foods,
breaking down perceived barriers to change, food swaps,
comfort eating and long-term maintenance. Participants
received a 2-weekly call from the research team to re-
solve any technical/access issues. At no stage was
additional coaching or feedback provided. For reasons
of health and safety, participants were provided with
an induction to the gym, and given full access to the
gym and swimming pool for the duration of the
intervention but were not allowed to access personal
training during this time. Participants were famil-
iarised with the basic American College of Sports
Medicine (ACSM) physical activity guidelines [23] and
how this would translate to the fitness and wellbeing
centre by way of a handout (Appendix 2).
Gym only
The gym only group received no guidance or formal
intervention. Following baseline assessments, partici-
pants were provided with an induction to the gym which
acted as a health and safety measure. Participants were
familiarised with the basic ACSM physical activity guide-
lines [23] and how this would translate to the fitness and
wellbeing centre by way of a handout (Appendix 2) but
were given no additional advice thereafter.
Data collection
All data were collected at baseline and 12 weeks and
were taken following a 12 h overnight fast. Blood
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analyses were done using venous blood samples col-
lected via venepuncture of the antecubital vein. Blood
samples were collected into vacutainers™ (Becton Dickin-
son, Plymouth, UK; SST™ II / 2KEDTA) for analysis of
plasma insulin, blood lipid profile, fasting blood glucose
and HbA1C. All samples were temporarily stored at 4 °C
and analysed within 24 h of collection. Plasma total chol-
esterol and triglycerides (free glycerol blank subtracted)
were measured enzymatically using established clinical
chemistry laboratory methods [24, 25] (Nuffield Health,
Glasgow, UK). High-density lipoprotein cholesterol
(HDL-C) was measured by liquid selective detergent
followed by enzymatic determination of cholesterol [26].
Low-density lipoprotein cholesterol (LDL-C) was calcu-
lated according to Friedewald et al. [27]. Total plasma
insulin in serum was measured by radioimmunoassay
[28] and blood glucose was measured using a modifica-
tion of the glucose oxidase/peroxidase method [29, 30].
A HPLC-ESI/MS approach was utilized to measure
blood HbA1c concentrations [31]. An estimation of in-
sulin resistance and β-cell function was provided via the
homeostasis model assessment as described elsewhere
(HOMA-IR [32],).
Anthropometric measurements were made according
to the recommendations of the International Standards
for Anthropometric Assessment (ISAK) [33]. Fat mass
and fat-free mass were assessed by bioelectrical imped-
ance analysis in accordance with manufacturer recom-
mendations (Bodystat 1500, Bodystat Ltd., UK). Blood
pressure and resting heart rate were measured via auto-
mated blood pressure cuff (Omron M3 Comfort, Omron
Corporation, Japan) in accordance with the European
Society of Hypertension guidance [34]. Mean arterial
pressure (MAP) was recorded and defined as [(2 x dia-
stolic) + systolic]÷3. Assessment of cardiovascular dis-
ease risk and T2DM risk assessed using the QRisk2 risk
calculator [35] and QDiabetes [36] risk calculator
respectively.
Statistical analysis
Data are presented as mean ± SD. Statistical analyses
were performed using IBM SPSS Statistics 23. As the
aim of the study was to establish differences in the ef-
fects of two interventions vs. a control condition rather
than establishing the effect of treatment assignments per
se, we chose to employ Per Protocol analysis rather than
Intention to Treat analysis. The primary outcome meas-
ure was the change in body mass from baseline to
follow-up. To detect differences between the effects of
the interventions on body mass with a medium effect
size of f = 0.25 we required 18 participants in each group
to achieve a power of 95% and α = 0.05. To allow for
drop out of participants during the study period we
aimed to recruit a sample size of 25 participants in each
group. A two-way mixed ANOVA (intervention x time)
was performed to determine the effects of the interven-
tions on the outcome measures, with the intervention x
time interaction effect as the main statistic of interest. In
the case of significant main effects, post-hoc comparisons
were performed using Fishers LSD (i.e. uncorrected
paired t-tests) since there is no inflation of type 1 error
rates following a significant main effect when only three
comparisons are being made [37]. Alpha was set at 0.05.
Results
Of the 76 participants who started (n = 25, 25, 26 for
HWP, NHS and GYM respectively), 13 withdrew citing
a declination to continue in the study (n = 7, 4, and 2 for
HWP, NHS and GYM respectively) (see Appendix 1 for
participant flow diagram). Table 1 presents the charac-
teristics of all starting participants and participants who
completed the study and were included in the Per Proto-
col analysis. There were no significant differences be-
tween groups at baseline.
Main effects of time were observed (Table 2), with re-
ductions in body mass (p < 0.001), BMI (p < 0.05), waist
(p < 0.001) and hip circumference (p < 0.001), absolute
body fat (kg, p < 0.001), fat free mass (p < 0.01), plasma
triglycerides (p < 0.01), LDL-C (p < 0.01), total choles-
terol:HDL cholesterol ratio (p < 0.05), fasting blood glu-
cose (p < 0.05), HbA1C (p < 0.05), and 10-year
cardiovascular disease risk according to the QRISK-2
score (p < 0.01), and an increase in plasma HDL-C (p <
0.01). No changes from pre- to post-intervention were
observed for percentage body fat, total cholesterol, insu-
lin, HOMA-IR, and T2DM risk (Q-Diabetes). A signifi-
cant intervention x time interaction effect was observed
for both body mass (p < 0.01) and BMI (p < 0.05).
Greater reductions in body mass were observed in HWP
(5%, p < 0.001) and NHS (4%, p < 0.001) compared to
GYM (1%) with no difference between the HWP and
NHS interventions (Fig. 1).
Discussion
The primary aim of this study was to evaluate the effect-
iveness of a resource-intensive commercial weight-loss
programme versus a free online NHS weight-loss inter-
vention and an active control condition. We hypothe-
sised that the more resource-intensive commercial HWP
intervention would result in superior reductions in body
mass compared to the NHS intervention and GYM con-
trol. However, despite the low cost and ease of delivery,
the free, online NHS intervention was comparable to the
commercially available, resource-intensive HWP inter-
vention in reducing body mass, with significantly greater
losses in body mass observed in both interventions com-
pared to the active-control GYM condition.
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This is the first study to demonstrate the effectiveness
of the free online NHS weight loss programme at enab-
ling individuals to achieve reductions in body mass. The
NHS resource has several useful additions on the associ-
ated web-page, including: automated support email sign-
up, access to a weight-loss forum, a calorie-checker, a
mobile app, and articles on success stories and tips to
overcoming barriers. This volume of additional support
options and the ability to access supportive content at
the participants’ leisure may explain the similarities in
results of the NHS intervention compared to the HWP
intervention, which does not provide access to such con-
tent outside of the face-to-face sessions, although usage
of additional content was not assessed in the current
study. A large volume of content including exercise vid-
eos is available at the Nuffield Health website, but par-
ticipants were not specifically made aware of this.
The UK Department of Health’s best practice guidance
for weight management [38] advises that weight loss
programmes must achieve measurable health outcomes.
Specifically, weight loss programmes should ensure that
interventions lead to an average weight loss of at least
3%, with at least 30% of participants losing at least 5% of
their initial weight. This target was met in the HWP and
NHS group, which further demonstrates the effective-
ness of the NHS weight loss plan. Whilst both HWP and
NHS groups achieved 5% weight loss in 50 and 38% of
participants respectively, the GYM group marginally
missed this target, achieving 3% weight loss in 29% of
participants, which may suggest that the observed effects
in the NHS and HWP groups was not merely because of
offering free gym access.
Heshka and colleagues [17] previously demonstrated
that weight loss was significantly greater following a
commercial weight loss programme (Weight Watchers;
− 4 kg) compared to a self-help programme (−1.5 kg).
This is at odds with the current findings, with the com-
mercial HWP group achieving 5.2 ± 4.2 kg weight loss
(5%) and the NHS self-help group achieving 4.2 ± 5.5 kg
weight loss (4%) with no statistical difference between
the two groups. A study by Baetge et al. [39] compared a
programme that incorporates both exercise and dietary
interventions (Curves) versus programmes that provide a
dietary intervention only but advocates for exercise
(Weight Watchers, Jenny Craig and Nutrisystem) and a
non-intervention control group, evaluated over a 12-
week period in a population of participants who were
overweight or obese. Data demonstrated significant re-
ductions in body mass versus a no-intervention control
for all groups. Briefly, these were translated in to the fol-
lowing percentage changes: Curves (a combined meal-
plan and exercise intervention) -4.7%, Weight Watchers
(a group based, points-orientated nutritional interven-
tion) -4.8%, Jenny Craig at Home (an online nutrition-
focussed intervention) -5.9%, and Nutrisystem Advance
Select (a meal-plan based system with online support)
-5.3%. The results of this study align to those of the
present study where a combined exercise and nutrition
intervention (HWP) was not superior to a nutrition
intervention which advocates for exercise (NHS). Fur-
thermore, a systematic review and meta-analysis of 26
studies examining remotely delivered standalone inter-
ventions to elicit eating behaviour change by Teasdale
et al [40] found a small but significant positive effect on
eating behaviour change compared to control groups.
The authors conclude that, albeit small, standalone self-
management or targeted feedback interventions – such
as the online NHS programme - could have an appre-
ciable impact at a population level.
A time x intervention interaction only existed for body
mass and BMI; however, a main effect of time showed
positive changes in several additional indices including:
waist circumference, HDL cholesterol, LDL cholesterol,
plasma triglycerides, and blood glucose. These findings
suggest that all three conditions elicited an improvement
in several health markers however the two main inter-
ventions were not superior to the active-control condi-
tion for any health marker out with body mass and BMI.
Table 1 Participant Characteristics
HWP NHS GYM
Starting Cohort
N = 25
Per Protocol
Analysis N = 18
Starting Cohort
N = 25
Per Protocol
Analysis N = 21
Starting Cohort
N = 26
Per Protocol
Analysis N = 24
Men / women 10 / 15 8 / 10 8 / 17 7 / 14 8 / 18 7 / 17
Age (y) 40 ± 8 (20–50) 43 ± 5 (33–50) 37 ± 8 (23–50) 37 ± 8 (23–50) 38 ± 7 (20–47) 37 ± 8 (20–47)
Height (m) 1.72 ± 0.10
(1.57–1.91)
1.72 ± 0.10
(1.57–1.86)
1.70 ± 0.11
(1.52–1.87)
1.71 ± 0.11
(1.52–1.90)
1.68 ± 0.09
(1.54–1.87)
1.68 ± 0.09
(1.54–1.87)
Body Mass (kg) 106.06 ± 15.66
(82.50–141.00)
106.38 ± 14.90
(89.50–140.00)
102.53 ± 16.79
(77.00–145.10)
103.13 ± 16.92
(77.00–145.10)
98.52 ± 13.32
(80.20–126.80)
98.98 ± 13.54
(80.20–126.80)
BMI (kg/m2) 36.01 ± 3.26
(30.00–41.20)
35.86 ± 3.42
(29.67–40.47)
35.31 ± 3.40
(29.71–41.76)
35.25 ± 3.51
(29.71–40.19)
34.78 ± 2.90
(30.07–40.11)
34.85 ± 2.97
(30.07–40.11)
Values shown are means ± SD (range)
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Results in the present study are at odds with Baetge and
colleagues [39] who showed significant pre to post im-
provements in the aforementioned following 12-weeks
of weight-loss interventions compared to their control
group. The present study and that of Baetge et al. [39]
differ somewhat however in that the present study in-
cludes both males and females and an active control
condition allowing for the assessment of both weight-
loss interventions in a ‘real-world’ setting whereas
Baetge and colleagues recruited women only and had a
no-intervention control. In the case of the present study,
although the primary aim was achieved, it is possible to
postulate that the inclusion of the “real-world” control
condition masked further between-group differences
seen in other studies that used no-intervention control
groups.
Current guidance from the National Institute Health
and Care Excellence [41] recommends that individuals
who are overweight or obese be referred to group rather
than individual programmes due to cost effectiveness.
This can include lifestyle weight management pro-
grammes delivered by the public, private or voluntary
sector. The NHS intervention in the current study offers
a potential opportunity that is scalable, cost effective and
can acutely achieve clinically significant weight loss simi-
lar to commercial lifestyle weight management pro-
grammes that patients are referred to such as Weight
Watchers [15] and slimming world.
Strengths and limitations
The addition of an active-control group was a strength
of the present study. We recruited a very motivated co-
hort who were randomised to three groups with varying
levels of support. Providing the control group with free
access to fitness facilities but no further support allowed
for the evaluation of both interventions in a ‘real-world’
setting.
The duration of the present study (12 weeks) is acute
and therefore longer-term outcomes are not known. A 6
and 12 –month follow-up was planned but was unable
to be conducted due to operational constraints within
the delivery organisation. This was unfortunate as a key
question about the long-term maintenance of weight-
loss following both interventions remains unanswered.
Future work requires detailed objective monitoring of
physical activity. Participants in the present study were
given access to fitness facilities however an unforeseen
error meant that usage data was not collected. The NHS
resource has several additions on the associated web-
page; although participants were made aware of this in-
formation, we were unable to track usage. It should also
be noted that the results in the present study may be ex-
plained by the fact that the present study had a very mo-
tivated cohort given that participants volunteered to take
part and therefore, results in the general population may
differ.
The present study was too small to derive reliable esti-
mates of adherence, and as such we chose to initially
examine the effectiveness of the two interventions at in-
ducing reductions in body mass. Now that we have
established that the free, online NHS programme does
not result in significantly lower reductions in body mass
compared to a resource-intensive commercial
programme, there is a need for future studies to estab-
lish possible differences in adherence and to utilise
Intention to Treat analysis rather than Per Protocol ana-
lysis as used in the present study [42].
Conclusion
This is the first study to evaluate the free online NHS
self-help weight-loss tool and compare it to a commer-
cial weight loss programme. Our findings suggest that
the NHS weight loss tool is an effective intervention for
reducing body mass in the short term, and that provid-
ing a more resource-intensive intervention does not ne-
cessarily yield additional benefits, at least in the short
term. Both interventions were superior compared to the
control group at eliciting a reduction in body mass. Al-
though current guidelines regarding weight-loss recom-
mend people are referred to group programmes due to
their cost-effectiveness, the current study demonstrates
clinically significant weight-loss can be achieved by a
free, online, scalable, self-help website. Thus, clinicians
and the NHS may have an alternative and effective op-
tion to support weight-loss, with potential additive bene-
fits expected should a structured exercise environment
be made available.
Fig. 1 Individuals’ post intervention changes in body mass
between groups
Innes et al. BMC Public Health         (2019) 19:1732 Page 7 of 10
Appendix 2
Gym-based Exercise Information Guide
Healthy Weight Study \ Nuffield Health Research Group
The American College of sports Medicine (ACSM)
recommend that each person performs: 150 min of
moderate of 75 min of vigorous intensity aerobic
exercise across 7 days, as well as 2 sessions of whole
body resistance exercises and at least 2 sessions working
on flexibility.
150 min of moderate intensity or 75 min of vigorous
intensity aerobic exercise per week
 Aerobic exercise improves your hearts efficiency as a
pump and when performed consistently, can reduce
your risk of virtually all lifestyle related diseases.
○ Moderate intensity – a 4–7 out of 10 in terms
of perceived effort. You are likely to have
increased breathing rate, perhaps be lightly
sweating; however, you should be able to keep this
intensity up for around an hour.
○ Vigorous intensity – an 8 out of 10 at least in
terms of intensity. You shouldn’t feel comfortable
at this intensity. You’re likely to be sweating
heavily and short of breath; however, you should
be able to speak in short phrases.
■ Example Moderate Intensity Exercises
 Continuous swimming
 Brisk Walking/light jogging
 Continuous cycling/stepper/rowing/cross
trainer
■ Example Vigorous Intensity Exercises
Appendix 1
Fig. 2 CONSORT flow diagram
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 Body Pump class
 Metafit Class
 Cycle Class
 Interval training on cardio machines
 Circuits Class
 Boxing Fit Class
Whole body resistance training at least twice per week:
 Resistance training typically involves performing
exercises against a force or weight for several
repetitions per set. There are many variations of
repetitions and sets but the general principles you
should follow are:
○ Perform at least 1 exercise per large muscle
group such as:
■ Leg Press Targets most muscles in your legs
■ Chest Press Targets most muscles in your
chest as well as arms
■ Seated row Targets muscles in your upper
and middle back and arms
○ You can utilise fixed weight machines or free-
weights depending on your experience. If you are
inexperienced, fixed-weight machines will guide
you safely.
○ Keep track of the exercises you do, the weights,
the repetitions and the sets you perform with a
view to increased one of these aspects each week
to continuously improve.
○ Performing 3 sets of 12–15 repetitions will be
sufficient to start with but you can increase/
decrease the sets/reps as you feel the need to, but
keep a note so you can improve next time you’re
in the gym
○ Some fitness classes will also count as resistance
training such as body pump and circuits.
Perform at least two sessions of flexibility exercises per
week:
 Working to improve and then maintain flexibility
across all major muscle groups at least twice per
week will help improve and maintain range of
motion in your joints and may help reduce certain
risks such as low back pain.
○ Performing a yoga class is a great way to learn
various stretches which you can then implement
into your workout routine
○ You can attend yoga classes for free during the
study.
Additional Information: For the duration of the study,
you will be unable to purchase Personal Training. For any
questions or issues, please contact one of the researchers.
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